Researchers are currently experimenting in laboratories on the bioavailability of oral-buccal administration of peptide to the subcutaneous route, and results so far show that 1mg of peptide sublingually administered daily is equivalent to 5mg weekly subcutaneously. The research aims to suggest alternative methods for alleviating redness, pain, swelling, and total body chills, as well as muscular pain, triggered by subcutaneous administration in approximately 20% of the population.

RapheGenerics custom-blends Tirzepatide with Glycine and B12 or Retatrutide with Glycine and B12 drop lozenges as one of the most successful products for weight loss for researchers. By combining dual-acting effects on craving centers, researchers have found the most success. This product will change your institution.

Custom packaged in 30-count packs, offering a 30-day supply or as required. Select flavors of your choice from mint, toffee, strawberry etc